Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Multicenter Study
. 2023 Sep;36(7):2013-2022.
doi: 10.1007/s40620-023-01708-7. Epub 2023 Jul 25.

Safety and efficacy of COVID-19 vaccines in patients on dialysis: a multicentre cohort study in Italy

Collaborators, Affiliations
Multicenter Study

Safety and efficacy of COVID-19 vaccines in patients on dialysis: a multicentre cohort study in Italy

Francesca Menniti-Ippolito et al. J Nephrol. 2023 Sep.

Erratum in

Abstract

Background: The aim of this study was to evaluate the efficacy and safety of COVID-19 vaccines in patients undergoing haemodialysis in Italy compared to the general population.

Methods: In this cohort study, 118 dialysis centres from 18 Italian Regions participated. Individuals older than 16 years on dialysis treatment for at least 3 months, who provided informed consent were included. We collected demographic and clinical information, as well as data on vaccination status, hospitalisations, access to intensive care units and adverse events. We calculated the incidence, hospitalisation, mortality, and fatality rates in the vaccinated dialysis cohort, adjusted for several covariates. The incidence rates of infection in the dialysis cohort and the general population were compared through Standardised Incidence Rate Ratio.

Results: The study included 6555 patients vaccinated against SARS-CoV-2 infection according to the schedule recommended in Italy. Between March 2021 and May 2022, there were 1096 cases of SARS-CoV-2 infection, with an incidence rate after completion of the three-dose vaccination cycle of 37.7 cases per 100 person-years. Compared to the general population, we observed a 14% reduction in the risk of infection for patients who received three vaccine doses (Standardised Incidence Rate Ratio: 0.86; 95% Confidence Interval: 0.81-0.91), whereas no statistically significant differences were found for COVID-19-related hospitalisations, intensive care unit admissions or death. No safety signals emerged from the reported adverse events.

Conclusions: The vaccination program against SARS-CoV-2 in the haemodialysis population showed an effectiveness and safety profile comparable to that seen in the general population.

Keywords: COVID vaccines; Cohort study; Dialysis; Effectiveness; Safety.

PubMed Disclaimer

References

    1. Levin A, Tonelli M, Bonventre J et al (2017) Global kidney health 2017 and beyond: a roadmap for closing gaps in care, research, and policy. Lancet 390:1888–1917. https://doi.org/10.1016/S0140-6736(17)30788-2 - DOI - PubMed
    1. Jager KJ, Kovesdy C, Langham R et al (2019) A single number for advocacy and communication—worldwide more than 850 million individuals have kidney diseases. Kidney Int 96:1048–1050. https://doi.org/10.1016/j.kint.2019.07.012 - DOI - PubMed
    1. de Nicola L, Donfrancesco C, Minutolo R et al (2015) Prevalence and cardiovascular risk profile of chronic kidney disease in Italy: results of the 2008–12 National Health Examination Survey. Nephrol Dial Transplant 30:806–814. https://doi.org/10.1093/NDT/GFU383 - DOI - PubMed
    1. Report 2010 – Ridt. https://ridt.sinitaly.org/2017/03/21/report-2010/ . Accessed 22 Sept 2022
    1. Jager KJ, Kramer A, Chesnaye NC et al (2020) Results from the ERA-EDTA registry indicate a high mortality due to COVID-19 in dialysis patients and kidney transplant recipients across Europe. Kidney Int. https://doi.org/10.1016/j.kint.2020.09.006 - DOI - PubMed - PMC

Publication types

Substances

LinkOut - more resources